News

Published on 10 May 2024 on Bloomberg via Yahoo Finance

Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal

Article preview image

(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot.

Most Read from Bloomberg

Elon Musk Pledges to Grow Supercharger Business He Just DecimatedBiden Set to Hit China EVs, Strategic Sectors With TariffsAckman Scolded Over DEI Views at Closed-Door Milken SessionApple Apologizes for iPad Pro Ad, Scraps Plan to Air It on TVNovavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal

Read the rest of the article
NASDAQ.SNY price evolution
PAR.SAN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
These 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts

In his iconic song The Gambler, Kenny Rogers famously sang, “Every hand’s a winner, and every han...

TipRanks · via Yahoo Finance 29 Oct 2024
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

Regeneron last year won approval for a higher-dose version of its star eye disease drug Eylea -- ...

The Motley Fool · via AOL 28 Oct 2024
Sanofi (SNY) Q3 2024 Earnings Call Transcript

Welcome to the Q3 2024 conference call for investors and analysts. As usual, you can find the sli...

The Motley Fool · via AOL 25 Oct 2024
...-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated...

The results show that Ebglyss improved skin (including hand and face) and itch among patients wit...

Benzinga · via Yahoo Finance 25 Oct 2024
Sanofi profit growth beats market view on early start of vaccine sales

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in ...

Reuters · via Yahoo Finance 25 Oct 2024
Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises...

On Friday, Sanofi SA (NASDAQ:SNY) reported a third-quarter business operating income of 4.61 bill...

Benzinga · via AOL 25 Oct 2024
Pharma Titan Eyes Breakout As Vaccine Sales Drive Beat

According to FactSet, the company posted profit of $1.54 per share on $14.51 billion in sales. Sa...

Investor's Business Daily 25 Oct 2024
Sanofi earnings boosted by Beyfortus, earlier vaccine sales

The company’s performance beat Wall Street expectations, pushing its share price higher in Friday...

BioPharma Dive · via Yahoo Finance 25 Oct 2024
Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises...

On Friday, Sanofi SA (NASDAQ:SNY) reported a third-quarter business operating income of 4.61 bill...

Benzinga · via Yahoo Finance 25 Oct 2024
Sanofi profit growth beats market view on early start of vaccine sales

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in ...

Reuters · via Yahoo Finance 25 Oct 2024

Copyright Statfolio @ 2024

Social Accounts